MGH researchers led the way, spearheading an international effort to study OCT, an imaging technology that could help doctors better understand atherosclerosis and guide optimal therapy for patients with coronary heart disease.
Researchers interested in collaboration should contact Iris McNulty, RN at imcnulty@mgh.harvard.edu.
Explore This Research Lab
Overview
Researchers at Mass General led the first optical coherence tomography (OCT) registry, an international database of 3,000 patients who received OCT. OCT is an intravascular imaging technique that may help physicians identify patients who are at increased risk for future heart attacks or sudden cardiac death.
To build the MGH OCT registry, we partnered with prominent institutions internationally. Using information gathered from the registry, it is our goal to provide knowledge that will help doctors improve their understanding of coronary atherosclerosis.
Why OCT Imaging?
By creating extremely high-resolution images from within the artery, OCT can pinpoint the microscopic characteristics of plaque, as opposed to intravascular ultrasound (IVUS), which is more widely used, but has a lower resolution. Currently OCT is the only intravascular imaging technique with the resolution sufficient enough (approximately 10 µm) to delineate fine structures, such as thin fibrous caps and to characterize plaque types, such as lipid rich plaque. OCT can also detect subtle structural changes after PCI, such as plaque disruption including tissue prolapse and protrusion after stenting with high accuracy.
Mass General Pioneers the Use of OCT Imaging
The MGH Coronary OCT Research Laboratory is a pioneer in the use of optical coherence tomography to view coronary arteries at an unprecedented level. Over the past two decades, we have led the way in using this technology by:
1999: Establishing the MGH Coronary OCT Research Laboratory
2002: Publishing the first in man study using OCT
2005: Publishing the first study on in vivo characterization of plaques in patients with different clinical presentation
2010: Establishing the first international cardiac OCT registry by collaborating with researchers from Australia, Korea, Japan and China
2010: Hosting the first international OCT symposium that brought together the world's thought leaders in OCT imaging
2013: Demonstrating the feasibility of making an in vivo diagnosis of plaque erosion
2016: Publishing the EROSION Study, which may lead to a major shift in the management of patients with acute coronary syndromes
2016: Establishing a new OCT research network with investigators from the United States, Japan, Italy, Belgium, Germany, Hong Kong Australia and India
2019: Proposing a new classification for calcified plaques in patients with acute coronary syndromes
2020: Collaborating on OCT studies enrolling subjects at sites in Japan including the collection of CTA (computed tomography angiography) images, and proteomic and microbiome samples
2021: Collaborating to develop deep learning models for OCT analysis
Publications
Dr. IK Jang’s laboratory has an extensive publication record which is available here.
Meet Our Team
The Mass General Optical Coherence Tomography (OCT) Registry is led by a team of world class researchers who have devoted their careers to pioneering OCT imaging. Meet the team behind the OCT registry, including:
Ik-Kyung Jang, MD, PhD is the Allan and Gill Gray Professor of Medicine at Harvard Medical School, and Director of the MGH Coronary OCT Laboratory at Massachusetts General Hospital.
Dr. Jang came to Massachusetts General Hospital in 1987 from Leuven University in Belgium, where he completed his residency in medicine and fellowship in cardiology. He also successfully defended his doctorate thesis at the same university. After his advanced fellowship in cardiology at Mass General, he joined the staff working as a physician and interventional cardiologist in the Cardiology Division. He continues to work as a cardiologist at MGH today.
His research interest has been acute coronary syndromes including acute myocardial infarction. His earlier research focused on pharmacology and physiology of thrombosis and thrombolysis including thrombin hypothesis and platelet inhibition. For the past twenty-four years he has pioneered the application of intravascular Optical Coherence Tomography (OCT) in patients to better characterize coronary plaques and to understand the mechanisms of plaque rupture. Dr. Jang was the first to perform an intravascular OCT procedure in a patient. In addition, he was the principal investigator for multiple US multicenter OCT trials. Dr. Jang has been invited to give lectures at numerous national and international meetings and has an extensive publications list. He received national recognition as the 2022 recipient of the Distinguished Scientist Award-Clinical Domain from the American College of Cardiology.
Hang Lee, PhD
Hang Lee, PhD, is the study statistician of the OCT Registry. Dr. Lee is Associate Professor of Medicine at Harvard Medical School and has experience in a wide range of collaborative research. At MGH, he is Associate Director for the Harvard Catalyst Biostatistics Program at Mass General and Associate Director of Collaborative Research and Consulting at the Mass General Biostatistics Center. He also serves as the statistical editor for the Journal of the American Society of Echocardiography (JASE). His statistical expertise is in longitudinal data, statistical genetics, clinical trials design and complex data analysis, and he has authored and co-authored over 350 clinical study articles.
Iris A. McNulty, RN, Laboratory Manager
Iris McNulty received a BA in Anthropology from Brown University and a BSN from Simmons College. She worked at Massachusetts General Hospital from 1995-2013, with a focus on Cardiology from 2000-2013, and as a clinical research nurse 2003-2013. She has significant experience working on OCT clinical trials and worked with Dr. Jang during the inception of the MGH OCT Registry. In June of 2019 Iris returned to MGH to work with Dr. Jang as the MGH Coronary OCT Lab Manager.
Haruhito Yuki
Haruhito Yuki, MD, is a research fellow who came from New Tokyo Hospital (Japan). He graduated from medical school in 2015, completed his residency training program at New Tokyo Hospital, and was a junior fellow at Tsuchiura Kyodo General Hospital. His research interests include coronary imaging, vascular biology, and clinical outcomes.
Daisuke Kinoshita
Daisuke Kinoshita, MD, PhD, came from Kitasato University (Japan) to work with Dr. Jang. He received his MD in 2009 and PhD in cardiovascular medicine in 2017 from Yamagata University. He is currently working on plaque vulnerability and vascular inflammation.
Keishi Suzuki
Keishi Suzuki, MD, PhD, is a research fellow who came from Nippon Medical School (Japan). He received his MD in 2010 and was subsequently trained at the same institution and affiliated institutions in Cardiology. He also received a PhD in 2018 from Nippon Medical School. His focus is on diabetes mellitus and plaque vulnerability.
Takayuki Niida
Takayuki Niida, MD, PhD, graduated from Shinshu University (Japan) in 2012 and completed his residency training program at Tokyo Medical and Dental University Hospital. In June 2022, after working at Tsuchiura Kyodo General Hospital and Tokyo Medical and Dental University Hospital, he came to Massachusetts General Hospital to work with Dr. Jang. His focus is on proteomics in OCT-defined high-risk coronary plaques.
Daichi Fujimoto
Daichi Fujimoto, MD, PhD, came from Kobe, Japan. He graduated from Kobe University School of Medicine in 2013 and obtained his PhD from Kobe University Graduate School of Medicine in 2022. He worked as a cardiology physician in Japan while conducting research at Saiseikai Nakatsu Hospital and Kobe University Hospital. He is currently focusing on calcification.
Marco Covani
Marco Covani, MD, is a Cardiology Resident from University Hospital of Parma (Italy). He graduated from University of Messina (Italy) in 2021. After that he moved to Parma to attend his Cardiology Residency where he is training as an Interventional Cardiologist and engaged in various research project. He joined Dr. Jang’s laboratory to conduct research focused on defining high-risk-plaque characteristics and plaque burden using multi-modality imaging techniques.
Former Fellows
Lena Seegers (2021-2022) – Cardiology Fellow Goethe University of Frankfurt
Akihiro Nakajima (2019-2022) – Cardiologist, New Tokyo Hospital, Tokyo, Japan
Makoto Araki (2019-2022) – Assistant Professor of Medicine, Tokyo Medical and Dental University, Tokyo, Japan
Hiroki Shinohara (2019) – Cardiologist, University of Tokyo
Osamu Kurihara (2018 – 2020) – Assistant Professor of Medicine Nippon Medical School, Chiba, Japan
Uncontrolled blood pressure puts people at increased risk of developing heart disease, brain disease, and kidney disease, yet only one in four people have their blood pressure under good control.
Noli Taylor’s ongoing chest tightness was more than minor pains. When scans revealed a rare congenital heart anomaly, clinicians at Martha’s Vineyard Hospital collaborated with experts at Mass General to diagnose the condition and perform a successful surgery to repair it.
Researchers from Mass General have found that engaging in recommended weekly amounts of physical activity—either concentrated in one to two days or spread throughout the week—may reduce the risk of a broad range of conditions.
On June 9, 2024, mother of three Kelli Shaw celebrated her 10-year wedding anniversary with a vow renewal ceremony. It is a milestone she nearly did not live to see following a medical emergency less than a year ago
This scientific statement outlines the current state-of-the-art on the use of artificial intelligence (AI), machine learning (ML) and data science in the diagnosis, classification and treatment of cardiovascular disease.
1of
6
Contact Us
Call or email us to learn more about our research.